166 related articles for article (PubMed ID: 3497054)
1. Sequential changes in antibody levels to the env and gag antigens in human immunodeficiency virus infected subjects.
Manca N; di Marzo Veronese F; Ho DD; Gallo RC; Sarngadharan MG
Eur J Epidemiol; 1987 Jun; 3(2):96-102. PubMed ID: 3497054
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of natural antibodies against five HTLV-III antigens in infected individuals: correlation of antibody prevalence with clinical status.
Franchini G; Robert-Guroff M; Aldovini A; Kan NC; Wong-Staal F
Blood; 1987 Feb; 69(2):437-41. PubMed ID: 3467797
[TBL] [Abstract][Full Text] [Related]
3. Antibody responses in early human immunodeficiency virus type 1 infection in hemophiliacs.
Chou MJ; Lee TH; Hatzakis A; Mandalaki T; McLane MF; Essex M
J Infect Dis; 1988 Apr; 157(4):805-11. PubMed ID: 3346572
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic significance of antibodies to HIV nuclear proteins in patients with the lymphadenopathy syndrome].
Schulte C; Meurer M; Fröschl M
Hautarzt; 1988 Jan; 39(1):45-8. PubMed ID: 3162727
[TBL] [Abstract][Full Text] [Related]
5. Analysis of human serum antibodies to human immunodeficiency virus (HIV) using recombinant ENV and GAG antigens.
Kenealy W; Reed D; Cybulski R; Tribe D; Taylor P; Stevens C; Matthews T; Petteway S
AIDS Res Hum Retroviruses; 1987; 3(1):95-105. PubMed ID: 3304356
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus infection in two cohorts of homosexual men: neutralising sera and association of anti-gag antibody with prognosis.
Weber JN; Clapham PR; Weiss RA; Parker D; Roberts C; Duncan J; Weller I; Carne C; Tedder RS; Pinching AJ
Lancet; 1987 Jan; 1(8525):119-22. PubMed ID: 2879968
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.
Wahren B; Morfeldt-Månsson L; Biberfeld G; Moberg L; Sönnerborg A; Ljungman P; Werner A; Kurth R; Gallo R; Bolognesi D
J Virol; 1987 Jun; 61(6):2017-23. PubMed ID: 3033328
[TBL] [Abstract][Full Text] [Related]
8. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients.
Barin F; McLane MF; Allan JS; Lee TH; Groopman JE; Essex M
Science; 1985 May; 228(4703):1094-6. PubMed ID: 2986291
[TBL] [Abstract][Full Text] [Related]
9. Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects.
Klasse PJ; Pipkorn R; Blomberg J
Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5225-9. PubMed ID: 2455899
[TBL] [Abstract][Full Text] [Related]
10. Antibodies reactive with human immunodeficiency virus gag-coded antigens (gag reactive only) are a major cause of enzyme-linked immunosorbent assay reactivity in a blood donor population.
Tribe DE; Reed DL; Lindell P; Kenealy WR; Ferguson BQ; Cybulski R; Winslow D; Waselefsky DM; Petteway SR
J Clin Microbiol; 1988 Apr; 26(4):641-7. PubMed ID: 3259246
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody identifies a highly conserved and immunodominant epitope of the human immunodeficiency virus transmembrane protein.
Papsidero LD; Poiesz BJ; Montagna RA
Hybridoma; 1988 Apr; 7(2):117-28. PubMed ID: 2453451
[TBL] [Abstract][Full Text] [Related]
12. Reactivity of an HIV gag gene polypeptide expressed in E. coli with sera from AIDS patients and monoclonal antibodies to gag.
Marcus-Sekura CJ; Woerner AM; Klutch M; Quinnan GV
Biochim Biophys Acta; 1988 Feb; 949(2):213-23. PubMed ID: 2449245
[TBL] [Abstract][Full Text] [Related]
13. HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with beta-thalassemia.
Robert-Guroff M; Giardina PJ; Robey WG; Jennings AM; Naugle CJ; Akbar AN; Grady RW; Hilgartner MW
J Immunol; 1987 Jun; 138(11):3731-6. PubMed ID: 3495568
[TBL] [Abstract][Full Text] [Related]
14. [Virus-specific antibody profile in various stages of HIV-1 infection. Western blot analysis of 170 patients].
Schulte C; Meurer M; Braun-Falco O; Held M; Fröschl M
Klin Wochenschr; 1988 Jun; 66(11):488-93. PubMed ID: 3165484
[TBL] [Abstract][Full Text] [Related]
15. Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.
Thorn RM; Beltz GA; Hung CH; Fallis BF; Winkle S; Cheng KL; Marciani DJ
J Clin Microbiol; 1987 Jul; 25(7):1207-12. PubMed ID: 3475281
[TBL] [Abstract][Full Text] [Related]
16. Serological characterization of HTLV-III infection in AIDS and related disorders.
Groopman JE; Chen FW; Hope JA; Andrews JM; Swift RL; Benton CV; Sullivan JL; Volberding PA; Sites DP; Landesman S
J Infect Dis; 1986 Apr; 153(4):736-42. PubMed ID: 3005434
[TBL] [Abstract][Full Text] [Related]
17. Comparison of recombinant human immunodeficiency virus gag precursor and gag/env fusion proteins and a synthetic env peptide as diagnostic reagents.
Shoeman RL; Young D; Pottathil R; Victor J; Conroy RR; Crowl RM; Coleman T; Heimer E; Lai CY; Ganguly K
Anal Biochem; 1987 Mar; 161(2):370-9. PubMed ID: 3495201
[TBL] [Abstract][Full Text] [Related]
18. Monitoring human immunodeficiency virus type 1-infected patients by ratio of antibodies to gp41 and p24.
Schmidt G; Amiraian K; Frey H; Wethers J; Stevens RW; Berns DS
J Clin Microbiol; 1989 May; 27(5):843-8. PubMed ID: 2501350
[TBL] [Abstract][Full Text] [Related]
19. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection.
Goudsmit J; Lange JM; Paul DA; Dawson GJ
J Infect Dis; 1987 Mar; 155(3):558-60. PubMed ID: 3468176
[No Abstract] [Full Text] [Related]
20. [Serologic AIDS diagnosis with polypeptides obtained by genetic technics of the human immunodeficiency virus (HIV-1)].
Lenz A; von Hintzenstern J; Erlwein O; Ellinger S; Bröker M; Fleckenstein B; Jahn G
Klin Wochenschr; 1987 Nov; 65(21):1042-7. PubMed ID: 3323645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
